Gaziantep City Hospital
Gaziantep, 27000, Turkey (Türkiye)
NCT Number: NCT07465055
Meningomyelocele is one of the most common neural tube defects requiring surgical repair in the neonatal period. Postoperative respiratory complications and the need for prolonged mechanical ventilation are important causes of morbidity in these patients. The timing of extubation may influence postoperative respiratory outcomes and the duration of neonatal intensive care unit (NICU) stay. This retrospective cohort study aims to evaluate the impact of operating room extubation on postoperative outcomes in neonates undergoing meningomyelocele repair at Gaziantep City Hospital. Clinical, laboratory, and perioperative data will be obtained from hospital records. Postoperative mechanical ventilation requirement, duration of ventilation, NICU length of stay, and perioperative laboratory changes will be compared between neonates extubated in the operating room and those extubated in the intensive care unit.
This study is active but is not currently recruiting participants.
Notify Me0 day–28 day
All sexes
Observational
Gaziantep, 27000, Turkey (Türkiye)
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Within the first 48 hours after surgery
Requirement for invasive mechanical ventilation after meningomyelocele repair in neonates.
Time frame: From surgery until discharge from the neonatal intensive care unit, up to 30 days
Duration of stay in the neonatal intensive care unit following meningomyelocele repair.
Time frame: Preoperative vs postoperative 24 hours
Difference between preoperative and postoperative blood pH values.
Time frame: Baseline (preoperative) and 24 hours after surgery
Difference between preoperative and postoperative blood lactate levels.
Gaziantep City Hospital
Other
Impact of Operating Room Extubation on Postoperative Outcomes in Neonates Undergoing Meningomyelocele Repair: A Retrospective Cohort Study
Acronym: MEROX
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04362592
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Los Angeles, California, United States
View Trial DetailsNCT03090633
Arnold-Chiari Malformation, Chiari Malformation Type 2
Baltimore, Maryland, United States
View Trial DetailsNCT03410667
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Indianapolis, Indiana, United States
View Trial DetailsNCT04243889
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Houston, Texas, United States
View Trial Details